Psychedelic Bulletin: MindMed Raises $34.5m; Tryp Goes Public; What Health Canada’s Latest Amendment Means for Psychedelics Post published:December 18, 2020 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Canadian Healthcare Professionals Allowed Psilocybin; UK Approves DMT Trial Post published:December 11, 2020 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Numinus & MAPS Seek Approval for MDMA Trial in Canada; Psychedelic Companies Commission Research into Psilocybin, DMT, LSD Post published:December 4, 2020 Post category:Psychedelic Bulletin
Psychedelic Bulletin: ATAI Raises $125m, MindMed CAD $25m; BBC Programme to Follow Psychedelics Trial Post published:November 27, 2020 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Non-Palliative Canadian Receives Psilocybin Therapy; Germany Backs Psilocybin Study; MindMed Moves Forward with LSD for ADHD Trial Post published:November 20, 2020 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Decrim Ambitions Spread to NJ and CA; Compass Shows Strong Cash Position; Cybin and Entheon Go Public Post published:November 13, 2020 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Psychedelics Decriminalised in OR and DC; Cybin and Entheon to Go Public Post published:November 6, 2020 Post category:Psychedelic Bulletin
Psychedelic Bulletin: MindMed Raises $28.75m, Entheon Inches Closer to Go-Public, Next Week’s Votes on Decriminalisation Post published:October 30, 2020 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Cybin Raises $45m, Numinus Harvests Psilocybe Mushrooms, New Psilocybin Clinical Trial Post published:October 23, 2020 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Swedish Psilocybin for Depression Trial Launches; Numinus Appoints Advisory Council Members; Field Trip Announces Partnership Post published:October 17, 2020 Post category:Psychedelic Bulletin